EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
EQHA.WS
EQHA.WS was delisted on the 25th of November, 2022.
57 hedge funds and large institutions have $7.05M invested in EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 4 closing their positions.
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
4% more funds holding
Funds holding: 55 → 57 (+2)
0% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 7
18% less capital invested
Capital invested by funds: $8.6M → $7.05M (-$1.55M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$159K |
| 2 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
+$103K |
| 3 |
SCM
Saba Capital Management
New York
|
+$54.7K |
| 4 |
CCM
Context Capital Management
Lajolla,
California
|
+$45.6K |
| 5 |
KJHP
K.J. Harrison & Partners
Toronto,
Ontario, Canada
|
+$38.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCL
Glazer Capital LLC
New York
|
-$159K |
| 2 |
Blackstone Inc
New York
|
-$65K |
| 3 |
RA
Ramius Advisors
New York
|
-$57K |
| 4 |
ICMH
Integrity Capital Management (HK)
Central,
Hong Kong
|
-$39K |
| 5 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$11.5K |
EQHA.WS Hedge Fund Activity: Q1 2022 in Review
57 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share (EQHA.WS) for Q1 2022, worth a combined $7.05M — down 18% from $8.6M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new EQHA.WS positions and 4 closed out — a net gain of 2 holders — while 7 added to existing stakes and 7 trimmed.
The largest buyer was Shaolin Capital Management, adding an estimated $159K. The largest seller was Glazer Capital LLC, cutting an estimated $159K.
- 57 institutional investors held EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share (EQHA.WS) as of Q1 2022, up from 55 in Q4 2021.
- Funds reported $7.05M of EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share stock for Q1 2022, down 18% quarter-over-quarter.
- 6 funds opened new EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share positions in Q1 2022 and 4 closed out, a net change of +2 holders.
- The largest EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share buyer in Q1 2022 was Shaolin Capital Management, an estimated $159K added.
- The largest EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share seller in Q1 2022 was Glazer Capital LLC, an estimated $159K sold.
Based on aggregated 13F filings for Q1 2022.